ELMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 105.6% based on the discounted cash flow analysis.
| Market cap | $377.98 Million |
|---|---|
| Enterprise Value | $361.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.9 |
| Beta | 0.5 |
| Outstanding Shares | 8,211,220 |
| P/E Ratio | 37.42 |
|---|---|
| PEG | 63.63 |
| Price to Sales | 5.29 |
| Price to Book Ratio | 8.46 |
| Enterprise Value to Revenue | 5.03 |
| Enterprise Value to EBIT | 27.29 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.12%▼ 53.45% |
|---|---|
| Total Invested | $408,618▼ 99.61% |
| Investors Holding | 3▼ 100.00% |
No data
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992.